Evidence map›Paper›PMID 32939234›Full record

ArticleJournal of extracellular vesicles2020

Stem cell-derived extracellular vesicles mitigate ageing-associated arterial stiffness and hypertension.

Rui Feng, Mujib Ullah, Kai Chen, Quaisar Ali, Yi Lin, Zhongjie Sun

Open access · goldAbstract read
In one paragraph

Article in Journal of extracellular vesicles, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 88 citations in OpenAlex.

  1. Review
  2. Review
  3. Fibulin 2 Deficiency Drives Epigenetic Hypertension.Hypertension (Dallas, Tex. : 1979) · 2026
    Article
  4. Review
  5. Microvascular Health as a Key Determinant of Organismal Aging.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Identification of potential biomarkers for hypertension based on transcriptomic analysis in rats.Hypertension research : official journal of the Japanese Society of Hypertension · 2025
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Rui FengDepartment of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Mujib UllahDepartment of Physiology, College of Medicine, University of Tennessee Health Sciences Center, Memphis, TN, USA.
Kai ChenDepartment of Physiology, College of Medicine, University of Tennessee Health Sciences Center, Memphis, TN, USA.
Quaisar AliDepartment of Physiology, College of Medicine, University of Tennessee Health Sciences Center, Memphis, TN, USA.
Yi LinDepartment of Physiology, College of Medicine, University of Tennessee Health Sciences Center, Memphis, TN, USA.
Zhongjie SunDepartment of Physiology, College of Medicine, University of Tennessee Health Sciences Center, Memphis, TN, USA.
University of Tennessee Health Science Center · USFirst Affiliated Hospital of Chongqing Medical University · CN

Funding

Investigation into Heart AgingR01AG049780 · NIA · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI SUN, ZHONGJIE · 2016 to 2020
$2.4M
Epigenetic Regulation of Kidney Function and Blood PressureR01AG062375 · NIA · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI SUN, ZHONGJIE · 2019 to 2023
$2.3M
Investigation into Arterial Stiffness and HypertensionR01HL154147 · NHLBI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI SUN, ZHONGJIE · 2020 to 2023
$2.2M
Coupling Factor 6 in Cold-induced Kidney Dysfunction and HypertensionR01HL122166 · NHLBI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI SUN, ZHONGJIE · 2015 to 2018
$1.5M
Anti-aging gene klotho: a novel therapeutic target in calcific aortic valve diseaseR01HL118558 · NHLBI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI SUN, ZHONGJIE · 2014 to 2017
$1.5M
NHLBI NIH HHS R01 HL118558NHLBI NIH HHS R01 HL122166NHLBI NIH HHS R01 HL154147NIA NIH HHS R01 AG049780NIA NIH HHS R01 AG062375
6 · The paper itself

Abstract

The prevalence of arterial stiffness and hypertension increases with age. This study investigates the effect of induced pluripotent mesenchymal stem cell-derived extracellular vesicles (EVs) on ageing-associated arterial stiffness and hypertension. EVs were collected and purified from induced pluripotent stem cell-derived mesenchymal stem cells (iPS-MSCs). Young and old male C57BL/6 mice were used. Mice in the EVs group were injected ABBREVIATIONS: EV: Extracellular vesicles; iPS: induced pluripotent stem cell; MSC: mesenchymal stem cell; AMPKα: AMP activated protein kinase α; eNOS: endothelial nitric oxide synthase; Sirt1: sirtuin 1; JNC7: Seventh Report of the Joint National Committee; CVD: cardiovascular disease; PWV: pulse wave velocity; BP: blood pressure; SNP: sodium nitroprusside.

Indexed as

AMPKarterial stiffnessExtracellular vesicleshypertensionSIRT1stem cell

Identifiers

PMID32939234
PMCPMC7480600
OpenAlexW3037426896

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.